Zepbound prescribed online, with a clear price for every kind of coverage
An AM Rx provider goes through your health history online and prescribes Zepbound® when it is appropriate. Our insurance coordination team then files the prior authorization.
- Tirzepatide acts on two hormone receptors, GIP and GLP-1, with one injection a week1
- Covered by your plan? Brand Zepbound copays start at $25/mo*
- Start without booking an appointment. Providers review intakes online
- Eligible adults anywhere in the 50 states or Washington, DC
A boxed warning applies to Zepbound: see the important safety information.
What exactly is Zepbound?
Zepbound is the name Eli Lilly gives tirzepatide when it is sold for weight. FDA approval came on November 8, 2023, for chronic weight management in adults who have obesity (BMI 30 or higher) or overweight (BMI 27 or higher) plus a weight-related condition.2 On December 20, 2024 the FDA added a sleep apnea approval.3
Single-dose pen, KwikPen or vial?
The device decides the price. LillyDirect listed three as of November 2026.4
- Single-dose pen: four a month, needle built in. The $25 savings card was written for this one.5
- KwikPen: a month of doses in a single pen, with a fresh needle each time.
- Single-dose vial: four a month, measured out by syringe, self-pay only.
Jump to prices for each dose.
Zepbound or compounded tirzepatide: what is the difference?
They share an ingredient and little else. Zepbound is the FDA-approved Lilly product tested in the trials described here. Compounded tirzepatide is mixed to order by a partner pharmacy. It has no FDA approval, and the FDA has not checked it for safety, effectiveness or quality.6 When prescribed, it costs $329 for one month, or from $216 a month if you order a 3-month supply. See our tirzepatide page.
*Requires a commercial plan that pays for Zepbound, and Eli Lilly’s Zepbound Savings Card, which has caps and expires December 31, 2026. Anyone on Medicare, Medicaid, TRICARE or VA benefits is excluded. Approval is up to your plan. †Lilly’s price, November 2026.5 Membership is charged apart from medication: $39 to start, then $135 monthly.
Safety in brief: Zepbound’s boxed warning concerns thyroid C-cell tumors. It is not for anyone with medullary thyroid carcinoma (MTC) in their own or their family’s history, or with MEN 2. Serious risks include pancreatitis and gallbladder disease. Go to the safety section.
Zepbound 15 mg took off 20.9% of body weight in its largest trial
SURMOUNT-1 enrolled 2,539 adults who had obesity or overweight but not diabetes, and ran for 72 weeks. The 5 mg group lost 15.0% of body weight on average, the 10 mg group 19.5% and the 15 mg group 20.9%. Placebo lost 3.1%.7 More than half of the 15 mg group (56.7%) shed at least a fifth of their weight, against 3.1% on placebo.1
Arithmetic on a trial average, not a forecast. The slider opens at 230 pounds because SURMOUNT-1 participants started at about 231.2 Everyone, placebo included, was also coached to cut roughly 500 calories a day and exercise at least 150 minutes a week.1 Your own result will differ.
Four more Zepbound trials
| Trial | Question it asked | Answer |
|---|---|---|
| SURMOUNT-2 | Does it work with type 2 diabetes? (938 adults, BMI 27 or higher, 72 weeks) | Weight loss of 12.8% (10 mg) and 14.7% (15 mg); placebo 3.2%.1 |
| SURMOUNT-4 | What if you stop after 36 weeks? (670 adults) | Staying on: 5.5% more lost over the following year. Moved to placebo: 14.0% regained.8 |
| SURMOUNT-5 | Tirzepatide or semaglutide? (751 adults, 72 weeks, open-label) | Tirzepatide 20.2%, semaglutide 13.7%.9 |
| SURMOUNT-OSA | Does it help sleep apnea with obesity? (469 adults, 52 weeks) | Hourly breathing interruptions dropped by 25.3 without PAP and 29.3 with PAP; placebo 5.3 and 5.5.10 |
Eli Lilly funded all five trials. The last one is covered in depth in Zepbound for sleep apnea.
What is Zepbound, and how does tirzepatide work?
Zepbound delivers tirzepatide by injection one time each week. The FDA has approved it for two uses in adults, each paired with eating fewer calories and moving more.1
How Zepbound works
One tirzepatide molecule turns on two receptors, GIP and GLP-1. According to the label, GLP-1 regulates appetite and calorie intake, and non-clinical studies suggest GIP may add to that. The upshot is that people eat less.1
The drug also holds food in the stomach longer, most of all after the first injection, which helps explain why stomach complaints come early. With a half-life near 5 days, weekly dosing reaches a steady level in about 4 weeks.1 Semaglutide, found in Wegovy® and Ozempic®, targets GLP-1 alone.11
Approved uses
- Weight: losing excess weight and holding the loss long term, for adults who have obesity, or overweight together with a weight-related condition.
- Sleep apnea: the obstructive kind, moderate to severe, in adults who also have obesity.
- Not approved for children, for type 2 diabetes or for heart disease. The diabetes brand of tirzepatide is Mounjaro®.1,12
- Not to be combined with another tirzepatide product or a GLP-1 medicine.
Zepbound next to compounded tirzepatide
| Feature | Brand ZepboundFDA-approved | Compounded tirzepatideNot FDA-approved |
|---|---|---|
| FDA status | Approved | Not approved. The FDA has not checked its safety, effectiveness or quality6 |
| Studied in trials | Yes, the SURMOUNT trials | No. Zepbound’s trial results do not carry over |
| Format | Pen, KwikPen or single-dose vial with a preset dose | Vial with added vitamin B12. Doses are measured with a syringe |
| Medication price | From $25/mo with a covering plan and Lilly’s card. See all prices | $329 for one month, or from $216/mo on a 3-month supply, shipped |
| Membership | $39 the first month and $135 monthly after that, whichever is prescribed. | |
The FDA’s position is that a compounded drug is for patients whose medical needs an approved drug cannot meet.6
Getting Zepbound through AM Rx, step by step
It all happens in your AM Rx account. Live visits are optional, and none is needed before you start.
1. Complete the intake
Join for $39 in month one, then answer questions about your health history, the medicines you take and what you want from treatment.

2. A provider reviews it
New intakes are usually read in 1 to 2 business days by a U.S.-licensed, board-certified physician or nurse practitioner, who replies by secure message and decides whether Zepbound is appropriate.

3. We send the prior authorization
Our insurance coordination team submits it to your plan. Plans usually answer within 2 to 14 business days. After a denial the team can try again, up to three requests in all. The decision is the plan’s, and a prior authorization stays active only while your membership does.

4. Pick your pharmacy
We send brand-name prescriptions to whichever pharmacy you choose. With coverage and Lilly’s card, copays can be as low as $25 monthly. Compounded tirzepatide (not FDA-approved), when that is what the provider prescribes, comes by mail from a partner pharmacy.

5. Move up in dose, with help
Each Zepbound step lasts four weeks or longer. Members can message their provider and care team as often as they like, work with a weight loss coach, use the AM Rx app, and ask for a video or phone visit each month.

Zepbound dosage: six steps from 2.5 mg to 15 mg
The first four weekly injections are 2.5 mg and the fifth is 5 mg. Later increases are 2.5 mg at a time, each after four weeks or more on the current dose, and 15 mg is the ceiling.1
| Dose | Earliest you can reach it | Its role |
|---|---|---|
| 2.5 mg | Week 1 | Starter. The label does not allow it long term. |
| 5 mg | Week 5 | First dose you can stay on for weight. |
| 7.5 mg | Week 9 | In-between step. |
| 10 mg | Week 13 | Stay-on dose for weight, and the lower of two for sleep apnea. |
| 12.5 mg | Week 17 | In-between step. |
| 15 mg | Week 21 | Highest dose, for weight or sleep apnea. |
Gradual increases keep stomach side effects down. A provider may pause at any step, or return you to a lower stay-on dose.1
Late or missed dose
You have 4 days (96 hours) from the scheduled time to take a late dose. Beyond that, skip it until your normal day. You may switch days if 72 hours separate the two injections.13
Injecting
Abdomen or thigh. Morning or evening, fed or fasted, makes no difference. The upper arm is only for injections another person gives you. Move to a new spot weekly.13
Storing
Refrigerate in the carton and do not freeze. Single-dose pens and vials can spend a combined 21 days out of the fridge, below 86°F. A KwikPen is finished 30 days after its first use.13
Brand pens and vials deliver a fixed volume, so there are no units to work out. For a compounded vial, which is not FDA-approved, use tirzepatide dosing in units.
Zepbound side effects, with rates for each dose
In the weight trials, 56% of people on any Zepbound dose had a stomach or bowel side effect, against 30% on placebo. Nausea, vomiting and diarrhea clustered in the dose-raising weeks, then tapered off.1
| Percent of people with | Placebo | On Zepbound | ||
|---|---|---|---|---|
| 5 mg | 10 mg | 15 mg | ||
| Any stomach or bowel effect | 30 | 56 | 56 | 56 |
| Nausea | 8 | 25 | 29 | 28 |
| Diarrhea | 8 | 19 | 21 | 23 |
| Vomiting | 2 | 8 | 11 | 13 |
| Constipation | 5 | 17 | 14 | 11 |
| Stomach pain | 5 | 9 | 9 | 10 |
| Injection site reactions | 2 | 6 | 8 | 8 |
| Hair loss | 1 | 5 | 4 | 5 |
Two 72-week weight trials pooled. Side effects made 4.8% (5 mg), 6.3% (10 mg) and 6.7% (15 mg) quit Zepbound, and 3.4% quit placebo.1
Hair loss went along with weight loss and was mostly reported by women: 7.1% of women on Zepbound and 0.5% of men. It made no one stop treatment.1
Easing side effects
- Smaller, more frequent meals. If nauseated in the first days on a dose, hold back on fatty and high-fiber food.14
- Constipated? More fluid, and fiber from food added a little at a time.14
- Drink through any vomiting or diarrhea. Dehydration can injure the kidneys.13
- Say so if a dose is rough. Your provider can delay the next step.1
Call for urgent help if you have
- Stomach pain that is severe and does not let up, possibly spreading to the back, whether or not you vomit.
- Upper belly pain together with clay-colored stools, yellowing skin or eyes, or a fever.
- Face, lips, tongue or throat swelling up, a struggle to breathe or swallow, a severe rash, fainting, or a racing heartbeat.13
- One eye losing vision suddenly.15
- A neck lump, a hoarse voice or difficulty swallowing (see the boxed warning).
Two label changes in 2026. February: the suicidal thoughts and behavior warning was deleted from Zepbound’s label at the FDA’s request, after an FDA review of 91 placebo-controlled trials (107,910 patients) showed no added risk.1,16 November 9: the FDA told makers of all GLP-1 medicines, Lilly among them, to put NAION, a rare, painless and sudden loss of sight in one eye, on their labels. Pooled trials showed 6.4 cases per 100,000 person-years on GLP-1 medicines and 3.8 on comparators.15
Zepbound cost: coupon, insurance and self-pay prices
A 28-day fill of Zepbound runs from $25 to a full list price of $1,086.37. Your coverage, your dose and the device (single-dose pen, KwikPen, vial) decide where you fall.5,17
| Situation | 28-day cost | Notes |
|---|---|---|
| Commercial plan covers Zepbound | From $25, single-dose pen | Lilly’s card absorbs as much as $100 monthly, $1,300 yearly.5 |
| Commercial plan refuses it | Single-dose pen $499. KwikPen $299, $399 or $449 by dose | Card required.5 |
| Uninsured, or choosing self-pay | Starter dose $299, 5 mg $399, higher doses $449 | KwikPen or four vials. $449 depends on refilling by day 45.4 |
| Medicare Part D | $50, KwikPen only, if you meet the Bridge criteria | No card. The Bridge ends December 31, 2027.18 |
| Full list price | $499 to $1,086.37 | Before insurance or discounts.17 |
December 31, 2026 deadline. The Zepbound Savings Card and the KwikPen Self-Pay Savings Card run out on that date as their terms now stand, and Lilly may withdraw the $449 refill offer whenever it likes. No 2027 terms had been posted on November 19, 2026.5 Recheck before a January fill.
Zepbound coupon: how the Savings Card works
Lilly issues one manufacturer coupon, called the Zepbound Savings Card. Layered over a commercial plan, it does one of three things.5
- The plan pays for the single-dose pen: $25 is the floor for a 1-month, 2-month or 3-month fill. The card contributes up to $100, $200 or $300 respectively, stopping at $1,300 and 13 fills in a calendar year.
- The plan refuses the single-dose pen: $499 per month at best, 13 fills a year at most.
- The plan refuses the KwikPen: $299, $399 or $449 as the dose rises, capped at 11 fills each calendar year.
Two examples. An $80 copay becomes $25, because the card pays $55. A $180 charge becomes $80, because the card stops at $100.
Who qualifies for the savings card, and who is shut out
Qualifies
- Commercial drug insurance, from an employer or bought yourself.
- A prescription for the single-dose pen or KwikPen, for an FDA-approved use.
- Adult (18+) resident of the United States or Puerto Rico.
Shut out
- Anyone enrolled in Medicare (Part D, Medicare Advantage and Medigap included), Medicaid, TRICARE, VA or Department of Defense coverage, or a state drug assistance program.
- Vial prescriptions.
- Plans tied to an alternate funding program.
- Anyone stacking it with a second coupon or cash discount card.
Federal law drives the government exclusion. Under the Anti-Kickback Statute it is a crime to knowingly pay anything of value to induce purchases that a federal health program pays for, and the HHS Office of Inspector General counts copay coupons as such payments.19
Zepbound cost with insurance
A commercial plan leaves you with its copay or coinsurance, and the card then knocks some of that off. Whether the plan pays for weight medication at all is the bigger question. KFF’s 2026 employer survey found that 18% of firms with 200 or more workers covered GLP-1 drugs for weight loss in their largest plan, rising to 33% among firms with 5,000 or more.20 If your plan wants a prior authorization, our coordination team files it. Use the GLP-1 insurance checker to prepare your questions.
Zepbound cost without insurance: LillyDirect self-pay prices by dose
Cash buyers pay $299, $399 or $449 per 28 days, the same for one KwikPen as for four single-dose vials. Lilly’s name for this pricing is the Zepbound Self-Pay Journey Program.4,5
| Dose | Lilly’s regular price | With a refill by day 45 |
|---|---|---|
| 2.5 mg | $299 | Same |
| 5 mg | $399 | Same |
| 7.5 mg | $499 | $449 |
| 10 mg | $699 | $449 |
| 12.5 mg | $699 | $449 |
| 15 mg | $699 | $449 |
Lilly self-pay, 28-day supply, November 2026. Tax and fees can be extra.5
At 7.5 mg and above, the first purchase is $449 automatically. Keeping that price means every later refill is purchased no more than 45 days after the previous fill arrived or was collected.5
- Supplies are extra. KwikPen needles, and syringes and needles for vials, are bought separately.4
- LillyDirect is the only seller of vials. Retail pharmacies sell the KwikPen at these prices to holders of the KwikPen Self-Pay Savings Card, capped at 11 fills each calendar year.5
- The single-dose pen is left out. It bottoms out at $499, and only with commercial insurance plus the card.5
- Nothing counts toward an insurance deductible or out-of-pocket maximum.5
A first-year example: $299 for the 2.5 mg fill, $399 for the 5 mg fill, then eleven on-time fills at $449 make $5,637 for thirteen fills, before supplies and tax. Someone who stays at 5 mg would spend $5,087. At the top list price, thirteen fills come to $14,122.81.
Medicare, Medicaid and Zepbound: what you pay
Neither program can be paired with the savings card.
- Medicare GLP-1 Bridge. Open since July 1, 2026 and scheduled to close on December 31, 2027. Part D enrollees who meet its criteria pay a $50 copay for a month of the Zepbound KwikPen prescribed for weight management. Single-dose pens and vials are left out.18,21 Eligibility starts at a BMI of 35. A BMI of 30 qualifies alongside diastolic heart failure, uncontrolled high blood pressure or chronic kidney disease (stage 3a or worse), and a BMI of 27 alongside prediabetes, an earlier heart attack or stroke, or symptomatic peripheral artery disease.21
- Medicare and sleep apnea. A diagnosis of moderate to severe sleep apnea rules you out of the Bridge. Medicare’s own page tells these patients their Part D plan “might cover” the medicine instead, so ask the plan.21
- Medicaid. KFF reports that Medicaid has to cover Zepbound prescribed for its sleep apnea indication. Obesity coverage is up to each state, and 13 state programs offered it for GLP-1 drugs in January 2026.22
- Self-pay. Lilly’s self-pay terms contain no exclusion for people with government coverage, but they forbid sending any claim for the purchase to an insurer or government program.5
What AM Rx charges
Membership costs $39 in the first month and $135 in each month after, with medication billed separately. It pays for provider review, insurance coordination, unlimited secure messaging, optional monthly visits, a weight loss coach and the app. Cancel in the portal whenever you like. HSA and FSA cards work.
- Zepbound with coverage: a copay that may come down to $25 a month. That depends on your plan, and no approval is promised.
- Zepbound without coverage: you pay your chosen pharmacy, at the Lilly prices shown above.
- Compounded tirzepatide, when prescribed: one month for $329, or a 3-month supply from $216 a month, shipping in the price. A bundle that combines membership and medication is $349 in month one and $449 monthly afterward. It is a different product from Zepbound and has no FDA approval.
Shopping around? Read our GoodRx and Wegovy guide and local and online tirzepatide options.
LillyDirect fills Zepbound orders but cannot prescribe
Eli Lilly runs LillyDirect as its own pharmacy channel for patients. It sells Zepbound and delivers it free, but a licensed provider outside LillyDirect has to write the prescription and send it in.4
LillyDirect carries the KwikPen (self-pay or select insurance), single-dose vials (self-pay only, sold nowhere else) and the single-dose pen (insurance). KwikPen and vial orders can also be collected at a retail pharmacy.4
| Question | AM Rx | LillyDirect |
|---|---|---|
| Prescribes Zepbound? | Yes, if a provider judges it appropriate | No, though it can refer you to independent providers |
| Insurance | Coordination team files prior authorizations | Bills insurance for the single-dose pen and some plans for the KwikPen |
| Dose and side effect help | Provider and care team, by secure message | The clinician who prescribed |
| Tirzepatide options | Zepbound, Mounjaro, or compounded tirzepatide (not FDA-approved) | Lilly brands only |
LillyDirect facts come from Lilly’s site, November 2026.4 AM Rx is not affiliated with Eli Lilly or LillyDirect.
Zepbound vs Wegovy, Mounjaro and Ozempic
Two of the four are approved to treat weight: Zepbound and Wegovy. Mounjaro and Ozempic are approved only for people with type 2 diabetes, which makes a weight-only prescription of either one off-label.
| Feature | Zepbound | Wegovy | Mounjaro | Ozempic |
|---|---|---|---|---|
| Ingredient | Tirzepatide (GIP + GLP-1) | Semaglutide (GLP-1) | Tirzepatide | Semaglutide |
| Approved uses | Long-term weight management; sleep apnea in people with obesity | Chronic weight management; lowering heart attack and stroke risk in adults who have heart disease plus overweight or obesity; the liver disease MASH | Type 2 diabetes, including heart risk reduction | Type 2 diabetes, including heart and kidney risk reduction |
| Stay-on weekly doses | 5 mg, 10 mg, 15 mg | 1.7 mg or 2.4 mg; 7.2 mg at most | 15 mg at most | 0.5 mg, 1 mg, 2 mg |
| Maker’s monthly self-pay | $299 to $449 | $349; 7.2 mg is $399 | From $499 | $349; 2 mg is $499 |
| Medicare GLP-1 Bridge | KwikPen | Included | Not included | Not included |
From each product’s label1,11,12,23 and each maker’s price page, November 2026.5,24,25,26 Bridge list from Medicare.21 New Wegovy and Ozempic patients can get the two lowest doses for $199 for two fills, until December 31, 2026.24,26
SURMOUNT-5 is the only trial that compared the two weight medicines directly: 20.2% weight loss with tirzepatide, 13.7% with semaglutide, over 72 weeks.9 Paying cash, Wegovy costs less than Zepbound at every dose from 5 mg up.
What AM Rx members say about the program
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.

A licensed provider decides whether Zepbound fits you
Because Zepbound carries a boxed warning, a U.S.-licensed physician or nurse practitioner goes through your health history before prescribing anything. Later questions about dose steps or side effects go to that same team.
The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.
Zepbound questions, answered
How much is Zepbound per month in November 2026?
Between $25 and $1,086.37 per 28-day fill. $25 takes commercial coverage for Zepbound plus the Lilly savings card. Cash buyers of the KwikPen or vials pay $299 on the 2.5 mg dose, $399 on 5 mg and $449 on anything higher. AM Rx membership is billed on top. See all prices.
Can I use the Zepbound coupon if I have no insurance?
No. Commercial drug insurance is a condition of the Zepbound Savings Card, even when that insurance refuses to pay for Zepbound. Uninsured buyers get Lilly’s self-pay pricing through LillyDirect, or the separate KwikPen Self-Pay Savings Card at retail pharmacies. Both start at $299 for 28 days. Card rules.
Why are Medicare and Medicaid patients barred from the Zepbound coupon?
Federal law. The Anti-Kickback Statute forbids payments meant to induce purchases a federal health program pays for, and regulators count copay coupons as such payments. Lilly’s terms therefore exclude everyone with government coverage. With Part D, look into the Medicare GLP-1 Bridge and its $50 KwikPen copay.
Will the Zepbound savings card still work in 2027?
Not known yet. The Zepbound Savings Card and the KwikPen Self-Pay Savings Card each expire on December 31, 2026, and Lilly had announced no 2027 terms by November 19, 2026. Lilly may also alter or stop an offer without warning, so read its savings page before your first January fill.
How does Lilly’s 45-day refill rule work?
It protects the $449 self-pay price at 7.5 mg and above. Your first purchase at those doses is $449. Every later refill must be bought within 45 days of the last fill reaching you. Past day 45, Lilly’s regular price returns: $499 for 7.5 mg, $699 for the three doses above it.
Does LillyDirect write Zepbound prescriptions?
No. LillyDirect is a pharmacy channel. It dispenses and ships Zepbound once a licensed provider has sent in a prescription, and it can refer you to independent providers. With AM Rx, a provider reviews your intake online and, when Zepbound is appropriate, sends the prescription to your chosen pharmacy.
Which is cheapest: Zepbound vials, the KwikPen or the single-dose pen?
For cash buyers, vials and the KwikPen tie at $299, $399 or $449 a month, set by dose. The single-dose pen never drops below $499 unless a plan covers it. Vials have two catches: only LillyDirect sells them, and syringes and needles are extra.
Is Zepbound on Medicare now?
Partly. The Medicare GLP-1 Bridge runs from July 1, 2026 to December 31, 2027. Part D enrollees who meet its BMI and health criteria pay a $50-a-month copay on the Zepbound KwikPen, after a prior authorization from their prescriber. Sleep apnea patients are outside the Bridge and should ask their Part D plan.
What are the usual Zepbound side effects, and when do they hit?
Nausea leads, then diarrhea, constipation and vomiting. In the weight trials, 25% to 29% of Zepbound users reported nausea, compared with 8% on placebo. These effects were concentrated in the weeks when doses were going up and grew rarer afterward. The label offers no timetable in days.
Will the weight come back if I quit Zepbound?
Much of it tends to. In SURMOUNT-4, people who had lost an average 20.9% over 36 weeks were randomly assigned to continue or to switch to placebo. Over the following year the placebo group regained 14.0%, while the group that continued lost 5.5% more.
Are Zepbound and Mounjaro the same medicine?
The medicine is identical: tirzepatide from Eli Lilly, in six matching strengths. The approvals are not. Zepbound is labeled for weight and for sleep apnea, Mounjaro for type 2 diabetes, so Mounjaro prescribed purely for weight is off-label. Compare them on the Mounjaro page.
How do I move from Wegovy or Ozempic to Zepbound?
With your provider, because no official conversion exists. The Zepbound label has no semaglutide equivalent, and Lilly states that 2.5 mg is the recommended starting dose. The two drugs must not overlap, since Zepbound is not to be used alongside any GLP-1 medicine.
Is Zepbound approved for sleep apnea?
Yes, with limits. The approval covers obstructive sleep apnea rated moderate to severe, in adults with obesity, at 10 mg or 15 mg. Two 52-week trials recorded 25 to 29 fewer breathing interruptions an hour, versus about 5 fewer on placebo. See Zepbound for sleep apnea.
Is a video call required before AM Rx prescribes Zepbound?
No. A licensed provider reviews your intake online, typically in 1 to 2 business days, and replies by secure message. Starting does not involve a live appointment. Members who prefer to talk can have a video or phone visit every month as part of membership.
My insurer refused Zepbound. What now?
There are three paths. Our coordination team can resubmit the prior authorization, up to three requests in total. You can buy Zepbound at Lilly’s self-pay price, $299 to $449 per 28 days. Or, when a provider considers it appropriate, compounded tirzepatide is available from $216 a month. It is not FDA-approved.
Keep reading
Important safety information
Reviewed by the AM Rx care team.
Boxed warning: thyroid C-cell tumors
In rat studies, tirzepatide led to tumors of the thyroid’s C cells. Nobody knows yet if the same happens in humans, and that includes medullary thyroid carcinoma (MTC), a thyroid cancer. Zepbound is off limits if MTC has ever been diagnosed in you or in a member of your family, and if you have MEN 2 (multiple endocrine neoplasia type 2). Report a neck lump or swelling, a hoarse voice, difficulty swallowing or breathlessness to your provider.1
People who must not take Zepbound
- Those with MTC in their own or their family’s history, and those with MEN 2.
- Those who reacted to tirzepatide, or to another ingredient of Zepbound, with a serious allergy.1
What your provider needs to know first
- Any pancreas trouble, now or in the past.
- Serious stomach conditions: gastroparesis (a stomach that empties slowly) or difficulty digesting food.
- Diabetic retinopathy at any time.
- Diabetes medicines you take, insulin and sulfonylureas above all.
- An operation or procedure coming up that involves anesthesia or deep sedation.
- Pregnancy, plans for pregnancy, or breastfeeding. An unborn baby may be harmed by Zepbound.
- Birth control pills, which can be less reliable. During the 4 weeks that follow your first dose, and again after every increase, use a non-pill contraceptive or add a barrier such as condoms.13
Serious side effects that can occur
Zepbound can cause pancreatitis (an inflamed pancreas); gallstones and other gallbladder disease; stomach problems severe enough that people with severe gastroparesis are advised against it; kidney damage when vomiting or diarrhea leaves you dehydrated; serious allergic reactions; low blood sugar, a bigger risk alongside insulin or a sulfonylurea; vision changes for people who have type 2 diabetes; and inhaling food or liquid into the lungs under anesthesia or deep sedation.1,13
The FDA is also requiring a warning about NAION, a rare cause of abrupt vision loss in one eye. It was not yet in Lilly’s label on November 19, 2026.15
Side effects reported most often
Nausea, diarrhea, vomiting and constipation, then abdominal pain, indigestion, reactions where you inject, tiredness, allergic reactions, belching, hair loss and heartburn.13
A KwikPen is for one person only, even with a new needle. This summary is no substitute for Lilly’s Prescribing Information and Medication Guide, or for your provider. The FDA takes side effect reports at 1-800-FDA-1088.
Sources
- Zepbound (tirzepatide) Prescribing Information. Eli Lilly; revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
- FDA Approves New Medication for Chronic Weight Management. FDA news release, November 8, 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
- FDA Approves First Medication for Obstructive Sleep Apnea. FDA news release, December 20, 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
- Eli Lilly. Zepbound through LillyDirect. https://www.lilly.com/lillydirect/zepbound
- Eli Lilly. Zepbound savings and card terms. https://zepbound.lilly.com/savings
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration, current as of October 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. https://pubmed.ncbi.nlm.nih.gov/38078870/
- Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
- Malhotra A, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity (SURMOUNT-OSA). N Engl J Med. 2024;391(13):1193-1205. https://pubmed.ncbi.nlm.nih.gov/38912654/
- Wegovy (semaglutide) Prescribing Information. Novo Nordisk; revised June 2026. https://www.novo-pi.com/wegovy.pdf
- Mounjaro (tirzepatide) Prescribing Information. Eli Lilly; revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
- Zepbound (tirzepatide) Medication Guide. Eli Lilly; revised August 2026. https://pi.lilly.com/us/zepbound-us-mg.pdf
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity (Silver Spring). 2025;33(8):1475-1503. https://pubmed.ncbi.nlm.nih.gov/40445127/
- FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition. FDA Drug Safety Communication, November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
- FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications. FDA Drug Safety Communication, January 13, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp
- Eli Lilly. Zepbound cost information (list price). https://pricinginfo.lilly.com/zepbound
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- HHS Office of Inspector General. Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons. September 2014. https://oig.hhs.gov/documents/special-advisory-bulletins/878/SAB_Copayment_Coupons.pdf
- KFF. 2026 Employer Health Benefits Survey. October 2026. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
- Medicare.gov. Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs
- KFF. Medicaid Coverage of and Spending on GLP-1s. January 2026. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
- Ozempic (semaglutide) Prescribing Information. Novo Nordisk; revised May 2026. https://www.novo-pi.com/ozempic.pdf
- Novo Nordisk. Wegovy cost and savings. https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
- Eli Lilly. Mounjaro savings and coverage. https://mounjaro.lilly.com/savings-coverage
- Novo Nordisk. Ozempic savings and self-pay prices. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
Prices and terms were checked on November 19, 2026 and can change without notice.
Ready to ask a provider about Zepbound?
Fill in the health questionnaire and a licensed provider will review it. The first month of AM Rx membership costs $39.
Get Started